MCLE · Medicale Corp. · Executive Compensation
$0.00
At close · Oct 7
Return incl. dividend (before tax)
Going-concern doubt
— flagged Feb 17, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has an accumulated deficit of $222,288 and a working capital deficit of $32,202 as of December 31, 2025. The Company currently has losses and has not completed its efforts to establish a stabilized source of revenues sufficient to cover operating costs over an extended period of time. Therefore, there is substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Feb 17, 2026
Market Cap
$2,368
Shares
5.92M
Volume · Oct 7
322
Avg daily vol (5 sessions)
2697
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Chen Zu De | Treasurer and Secretary | Appointed | 2023-01-09 |
| Chen Zu De | Director | Appointed | 2023-01-09 |
| Chen Zu De | Chairman of the Board | Appointed | 2023-01-09 |
| Chen Zu De | Chief Executive Officer | Appointed | 2023-01-09 |
| Borisi Alborovi | sole officer and director | Resigned | 2023-01-09 |
Leadership
- Chen Zu De CEO, Chairman, Board Member